ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2012 069 690.7, EP file number: 12 75 9652.6, WO file number: PCT/EP2012/003810 (Designation/title: OPHTHALMISCHE ZUSAMMENSETZUNGEN ENHALTEND PROSTAGLANDIN-F2-ALPHA-DERIVATE UND HYALURONSÄURE)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Mar 21, 2013Mar 21, 2013 unchanged
2 Q10 Document published Aug 13, 2014Aug 13, 2014 Filing
3 Q10 Document published Sep 25, 2014Sep 25, 2014Sep 25, 2014 Filing
4 Q10 Document published Apr 29, 2020Apr 29, 2020 Examination
5 Q10 Document published May 14, 2020May 14, 2020May 14, 2020 Examination
6 F10 IP right granted Feb 1, 2021Feb 1, 2021Apr 22, 2021 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Mar 21, 2013Mar 21, 2013 unchanged
2 Q12 Application published Aug 13, 2014Aug 13, 2014 Filing
3 Q10 Document published Sep 25, 2014Sep 25, 2014Sep 25, 2014 Filing
4 P22 Classification modified Dec 3, 2019Dec 3, 2019 Filing
5 Q10 Document published Apr 29, 2020Apr 29, 2020 Examination
6 Q10 Document published May 14, 2020May 14, 2020May 14, 2020 Examination
7 F10 IP right granted Feb 1, 2021Feb 1, 2021Apr 22, 2021 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data